# OnCo record nct06109272 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06109272/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06109272", "NCT06109272" ;
  schema:name "A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)"@en ;
  schema:alternateName "LIVIGNO-2"@en ;
  schema:description "A phase 2/3 trial testing Budigalimab in hepatocellular carcinoma, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06109272/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06109272> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2024-01-11" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/hcc-advanced/> ;
  onco:drugs <https://onco.cc/drugs/budigalimab/>, <https://onco.cc/drugs/livmoniplimab/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .